NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

seekazy,



Thanks for posting your free expert opinion on the PIII clinical trial, but we’ll leave the analyses & conclusions to the independent peer reviewers, the
FDA, & the respected physicians who led the trial.

Dr. Ashkan

Dr. Liau

To clarify the mis- or disinformation, & for details about the DCVax®-L PIII clinical trial, the most comprehensive resource is the independent peer review that was published in JAMA Oncology.



☑️ There are multiple trials & trial designs relevant to NWBO that include either a DCVax product or Roswell’s aDC1 platform.

☑️ Beyond the PIII ECA, DCVax®-L is also being studied in a RCT setting with placebo group.

☑️ As a matter of record, OS was always one of the endpoints for the PIII, but OS replaced PFS as the primary endpoint.